The Rising Burden of Fatty Liver Disease in the Middle East: Why Oman Must Act Now?
作者信息
Al-Busafi Said A
机构信息
Department of Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
出版信息
Oman Med J. 2025 Jan 31;40(1):e707. doi: 10.5001/omj.2025.90. eCollection 2025 Jan.
Abstract
摘要
相似文献
1
The Rising Burden of Fatty Liver Disease in the Middle East: Why Oman Must Act Now?中东地区脂肪肝疾病负担日益加重：阿曼为何必须立即行动？
Oman Med J. 2025 Jan 31;40(1):e707. doi: 10.5001/omj.2025.90. eCollection 2025 Jan.
2
Epidemiological trends and burden of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa region: a 32-year analysis of health impact.中东和北非地区代谢功能障碍相关脂肪性肝病的流行病学趋势与负担：一项为期32年的健康影响分析
J Health Popul Nutr. 2025 Jun 18;44(1):207. doi: 10.1186/s41043-025-00973-5.
3
Global, regional, and national time trends in prevalence of metabolic dysfunction associated steatotic liver disease among women of reproductive age: an age-period-cohort analysis for the global Burden of Disease 2021 study.育龄期女性中代谢功能障碍相关脂肪性肝病患病率的全球、区域和国家时间趋势：全球疾病负担2021研究的年龄-时期-队列分析
Ann Med. 2025 Dec;57(1):2536759. doi: 10.1080/07853890.2025.2536759. Epub 2025 Jul 26.
4
Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort.阿曼的青少年皮肌炎：来自全国队列的临床模式和疾病轨迹
Pediatr Rheumatol Online J. 2025 Jul 17;23(1):75. doi: 10.1186/s12969-025-01132-0.
5
Navigating the path less taken: Exploring the experiences and challenges of undergraduate male nursing students in Oman.探索鲜有人走的道路：探究阿曼本科男护生的经历与挑战。
J Prof Nurs. 2025 Jul-Aug;59:1-9. doi: 10.1016/j.profnurs.2025.04.008. Epub 2025 Apr 15.
6
Unmet needs and emotional well-being of family caregivers of adult patients with cancer in Oman: a cross-sectional study.阿曼成年癌症患者家庭照顾者未满足的需求及情绪健康状况：一项横断面研究
Support Care Cancer. 2025 Jun 21;33(7):606. doi: 10.1007/s00520-025-09680-7.
7
Palliative care knowledge and attitudes towards end-of-life care of nurses in tertiary hospitals.三级医院护士对临终关怀的姑息治疗知识及态度
Curationis. 2025 Jul 28;48(1):e1-e9. doi: 10.4102/curationis.v48i1.2734.
8
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.减重手术与非酒精性脂肪性肝病：肝脏生物化学与组织学的系统评价
Obes Surg. 2015 Dec;25(12):2280-9. doi: 10.1007/s11695-015-1691-x.
9
Burden and inequality of autism spectrum disorders in global, East asian, and Southeast Asian regions, 1990-2021: result from the global burden of disease study 2021.1990 - 2021年全球、东亚和东南亚地区自闭症谱系障碍的负担与不平等：全球疾病负担研究2021的结果
BMC Public Health. 2025 Aug 16;25(1):2810. doi: 10.1186/s12889-025-23904-9.
10
Public health impact of adjuvanted RSVPreF3 vaccine in older adults: a modeling study in nine countries in Middle East and North Africa.佐剂RSVPreF3疫苗对老年人的公共卫生影响：中东和北非九个国家的建模研究
Expert Rev Vaccines. 2025 Jul 28. doi: 10.1080/14760584.2025.2539886.
本文引用的文献
1
Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study.阿曼HBeAg阴性慢性乙型肝炎病毒感染患者显著肝纤维化的患病率及危险因素：一项回顾性研究
Oman Med J. 2024 Nov 30;39(6):e693. doi: 10.5001/omj.2024.113. eCollection 2024 Nov.
2
Steatotic liver disease.脂肪变性肝疾病。
Lancet. 2024 Nov 2;404(10464):1761-1778. doi: 10.1016/S0140-6736(24)01811-7.
3
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
4
A systematic review of school-based weight-related interventions in the Gulf Cooperation Council countries.海湾合作委员会国家基于学校的体重相关干预措施的系统评价。
Syst Rev. 2024 Feb 14;13(1):66. doi: 10.1186/s13643-024-02475-7.
5
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019.从 1990 年到 2019 年，全球各地区非酒精性脂肪性肝病（NAFLD）的负担正在迅速增加。
Hepatol Commun. 2023 Oct 2;7(10). doi: 10.1097/HC9.0000000000000251. eCollection 2023 Oct 1.
6
Obesity and lifestyle behaviours among in-school children in Oman.阿曼在校儿童的肥胖与生活方式行为
East Mediterr Health J. 2023 Sep 9;29(9):716-724. doi: 10.26719/emhj.23.095.
7
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的全球流行病学：系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
8
Hepatitis B Related Liver Cirrhosis in Oman.阿曼的乙型肝炎相关肝硬化
Oman Med J. 2022 May 31;37(3):e384. doi: 10.5001/omj.2022.54. eCollection 2022 May.
9
Prevalence of Non-alcoholic Fatty Liver Disease among Patients with Diabetes Mellitus Attending Primary Health Care Centers in Bahrain.巴林初级卫生保健中心糖尿病患者中非酒精性脂肪性肝病的患病率
Oman Med J. 2022 Mar 22;37(2):e350. doi: 10.5001/omj.2022.53. eCollection 2022 Mar.
10
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?全球非酒精性脂肪性肝病政策审查与准备指数：各国是否准备好应对这一无声的公共卫生挑战？
J Hepatol. 2022 Apr;76(4):771-780. doi: 10.1016/j.jhep.2021.10.025. Epub 2021 Dec 9.
Zotero 插件